Literature DB >> 27393461

Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.

Rachel M Enga1, Asti Jackson1, M Imad Damaj2, Patrick M Beardsley3.   

Abstract

Abuse of prescription opioids, such as oxycodone, has markedly increased in recent decades. While oxycodone's antinociceptive effects have been detailed in several preclinical reports, surprisingly few preclinical reports have elaborated its abuse-related effects. This is particularly surprising given that oxycodone has been in clinical use since 1917. In a novel oral operant self-administration procedure, C57BL/6J mice were trained to self-administer water before introducing increasing concentrations of oxycodone (0.056-1.0mg/ml) under post-prandial conditions during daily, 3-h test sessions. As the concentration of oxycodone increased, the numbers of deliveries first increased, then decreased in an inverted U-shape fashion characteristic of the patterns of other drugs self-administered during limited access conditions. After post-prandial conditions were removed, self-administration at the highest concentration was maintained suggesting oral oxycodone served as a positive reinforcer. In other mice, using a novel regimen of physical dependence, mice were administered increasing doses of oxycodone (9.0-33.0mg/kg, s.c.) over 9 days, challenged with naloxone (0.1-10.0mg/kg, s.c.), and then observed for 30min. Naloxone dose-dependently increased the observed number of somatic signs of withdrawal, suggesting physical dependence of oxycodone was induced under this regimen. This is the first report demonstrating induction of oral operant self-administration of oxycodone and dose-dependent precipitations of oxycodone withdrawal in C57BL/6J mice. The use of oral operant self-administration as well as the novel physical dependence regimen provides useful approaches to further examine the abuse- and dependence-related effects of this highly abused prescription opioid.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dependence; Mouse; Oral self-administration; Oxycodone; Prescription opioid

Mesh:

Substances:

Year:  2016        PMID: 27393461      PMCID: PMC5824624          DOI: 10.1016/j.ejphar.2016.07.006

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  30 in total

Review 1.  Neuroadaptive effects of active versus passive drug administration in addiction research.

Authors:  Edwin H Jacobs; August B Smit; Taco J de Vries; Anton N M Schoffelmeer
Journal:  Trends Pharmacol Sci       Date:  2003-11       Impact factor: 14.819

2.  Effects of opiates and opiate antagonists on the Straub tail reaction in mice.

Authors:  M D Aceto; D B McKean; J Pearl
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

Review 3.  Self administration of and behavioral dependence on drugs.

Authors:  C R Schuster; T Thompson
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

4.  Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors.

Authors:  Michael A Emery; M L Shawn Bates; Paul J Wellman; Shoshana Eitan
Journal:  Behav Brain Res       Date:  2015-01-21       Impact factor: 3.332

5.  Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.

Authors:  Jason M Wiebelhaus; D Matthew Walentiny; Patrick M Beardsley
Journal:  J Pharmacol Exp Ther       Date:  2015-10-21       Impact factor: 4.030

6.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

7.  Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.

Authors:  Tomohisa Mori; Sachiko Komiya; Naoki Uzawa; Koichi Inoue; Toshimasa Itoh; Shiyou Aoki; Masahiro Shibasaki; Tsutomu Suzuki
Journal:  Eur J Pharmacol       Date:  2013-05-23       Impact factor: 4.432

8.  Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.

Authors:  Patrick M Beardsley; Mario D Aceto; Charles D Cook; Edward R Bowman; Jennifer L Newman; Louis S Harris
Journal:  Exp Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.157

9.  Differential establishment and maintenance of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains.

Authors:  T Suzuki; F R George; R A Meisch
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  Endothelin ETA receptor antagonist reverses naloxone-precipitated opioid withdrawal in mice.

Authors:  Shaifali Bhalla; Gwendolyn Pais; Melissa Tapia; Anil Gulati
Journal:  Can J Physiol Pharmacol       Date:  2015-04-28       Impact factor: 2.273

View more
  16 in total

1.  The effect of quinine in two bottle choice procedures in C57BL6 mice: Opioid preference, somatic withdrawal, and pharmacokinetic outcomes.

Authors:  Travis W Grim; Scarlet Jinhong Park; Cullen L Schmid; Robert B Laprairie; Michael Cameron; Laura M Bohn
Journal:  Drug Alcohol Depend       Date:  2018-08-02       Impact factor: 4.492

2.  Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions.

Authors:  Jacques D Nguyen; Yanabel Grant; Kevin M Creehan; Candy S Hwang; Sophia A Vandewater; Kim D Janda; Maury Cole; Michael A Taffe
Journal:  Neuropharmacology       Date:  2019-04-11       Impact factor: 5.250

3.  Sex and heredity are determinants of drug intake in a novel model of rat oral oxycodone self-administration.

Authors:  Burt M Sharp; Xinyu Fan; Eva E Redei; Megan K Mulligan; Hao Chen
Journal:  Genes Brain Behav       Date:  2021-09-16       Impact factor: 3.449

4.  Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.

Authors:  Virginia D McLane; Ivy Bergquist; James Cormier; Deborah J Barlow; Karen L Houseknecht; Edward J Bilsky; Ling Cao
Journal:  Life Sci       Date:  2017-07-16       Impact factor: 5.037

5.  Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.

Authors:  Adam Kimbrough; Jenni Kononoff; Sierra Simpson; Marsida Kallupi; Sharona Sedighim; Kenia Palomino; Dana Conlisk; Jeremiah D Momper; Giordano de Guglielmo; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2020-02-29       Impact factor: 4.530

6.  Prophylactic vaccination protects against the development of oxycodone self-administration.

Authors:  Jacques D Nguyen; Candy S Hwang; Yanabel Grant; Kim D Janda; Michael A Taffe
Journal:  Neuropharmacology       Date:  2018-06-22       Impact factor: 5.250

7.  Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal.

Authors:  Mohit Kumar; Jennifer R Rainville; Kori Williams; Joshua A Lile; Georgia E Hodes; Fair M Vassoler; Jill R Turner
Journal:  Neuropharmacology       Date:  2021-01-22       Impact factor: 5.250

8.  Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis.

Authors:  Jacques D Nguyen; Yanabel Grant; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2021-06-08       Impact factor: 9.473

9.  Aversion-resistant fentanyl self-administration in mice.

Authors:  Sean C Monroe; Anna K Radke
Journal:  Psychopharmacology (Berl)       Date:  2020-11-23       Impact factor: 4.530

10.  Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats.

Authors:  Hannah D Fulenwider; Sadie E Nennig; Hiba Hafeez; Michaela E Price; Federico Baruffaldi; Marco Pravetoni; Kejun Cheng; Kenner C Rice; Daniel F Manvich; Jesse R Schank
Journal:  Addict Biol       Date:  2019-12-12       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.